The Ensign Group (NASDAQ:ENSG) Price Target Lowered to $202.00 at Truist Financial

The Ensign Group (NASDAQ:ENSG) had its price target lowered by Truist Financial from $215.00 to $202.00 in a research report report published on Tuesday, MarketBeat.com reports. The firm currently has a hold rating on the stock.

Several other equities research analysts have also issued reports on the stock. Zacks Research lowered shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Wall Street Zen upgraded The Ensign Group from a “hold” rating to a “buy” rating in a research note on Sunday, June 14th. Royal Bank Of Canada reissued an “outperform” rating on shares of The Ensign Group in a report on Tuesday, June 9th. Finally, Weiss Ratings downgraded The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, June 16th. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $213.50.

The Ensign Group Price Performance

Shares of NASDAQ ENSG opened at $166.73 on Tuesday. The company has a market capitalization of $9.74 billion, a PE ratio of 27.15, a PEG ratio of 1.65 and a beta of 0.69. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.06. The stock’s 50 day moving average price is $166.06 and its 200-day moving average price is $184.19. The Ensign Group has a twelve month low of $134.79 and a twelve month high of $218.00.

The Ensign Group (NASDAQ:ENSG) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.79 by $0.06. The company had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.40 billion. The Ensign Group had a return on equity of 16.78% and a net margin of 6.89%.The Ensign Group’s revenue was up 18.4% on a year-over-year basis. During the same period last year, the business posted $1.52 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. On average, equities analysts anticipate that The Ensign Group will post 6.82 EPS for the current year.

The Ensign Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be issued a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Tuesday, June 30th. The Ensign Group’s dividend payout ratio (DPR) is presently 4.23%.

Insider Buying and Selling at The Ensign Group

In other news, Director Barry M. Smith sold 700 shares of The Ensign Group stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total value of $114,996.00. Following the completion of the transaction, the director directly owned 21,352 shares in the company, valued at approximately $3,507,706.56. The trade was a 3.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of The Ensign Group stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $199.97, for a total value of $78,388.24. Following the transaction, the director directly owned 9,295 shares of the company’s stock, valued at $1,858,721.15. The trade was a 4.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 1,892 shares of company stock valued at $340,591. 4.00% of the stock is owned by company insiders.

Institutional Investors Weigh In On The Ensign Group

Large investors have recently added to or reduced their stakes in the business. Baillie Gifford & Co. grew its position in The Ensign Group by 62.1% in the fourth quarter. Baillie Gifford & Co. now owns 4,569,254 shares of the company’s stock worth $795,964,000 after acquiring an additional 1,750,645 shares in the last quarter. Wasatch Advisors LP raised its position in The Ensign Group by 6.0% during the second quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company’s stock valued at $548,961,000 after purchasing an additional 199,983 shares in the last quarter. Geode Capital Management LLC raised its position in The Ensign Group by 3.4% during the fourth quarter. Geode Capital Management LLC now owns 1,498,673 shares of the company’s stock valued at $261,107,000 after purchasing an additional 49,117 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its stake in The Ensign Group by 9.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,332,505 shares of the company’s stock worth $232,124,000 after purchasing an additional 118,110 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in The Ensign Group by 0.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,090,838 shares of the company’s stock worth $190,033,000 after purchasing an additional 5,458 shares during the last quarter. Institutional investors own 96.12% of the company’s stock.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.